The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-α2b and ribavirin in patients with HBV/HCV co-infection

This publication has 36 references indexed in Scilit:

• Sustained HCV-RNA response and hepatitis Bs seroconversion after individualized antiviral therapy with pegylated interferon α plus ribavirin and active vaccination in a hepatitis C virus/hepatitis B virus-coinfected patient
  European Journal of Gastroenterology & Hepatology, 2007
• Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virus-(HBV-)Infektion: „Upgrade” der Leitlinie, AWMF-Register-Nr.: 021/011
  Zeitschrift für Gastroenterologie, 2007
• Favorable effect of adefovir on the number and functionality of myeloid dendritic cells of patients with chronic HBV†
  Hepatology, 2006
• Treating viral hepatitis C: efficacy, side effects, and complications
  Gut, 2006
• Hepatitis C virus eradication followed by HBeAg to anti-HBe seroconversion after pegylated interferon-??2b plus ribavirin treatment in a patient with hepatitis B and C coinfection
  European Journal of Gastroenterology & Hepatology, 2006
• Chronic hepatitis B
  Hepatology, 2005
• Combination therapy with interferon‐α and ribavirin in patients with dual hepatitis B and hepatitis C virus infection
  Journal of Gastroenterology and Hepatology, 2005
• Combined interferon plus lamivudine treatment in young patients with dual HBV (HBeAg positive) and HCV chronic infection
  Journal of Hepatology, 2004
• Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B
  New England Journal of Medicine, 2004
• Ribavirin and Interferon Is Effective for Hepatitis C Virus Clearance in Hepatitis B and C Dually Infected Patients
  Hepatology, 2003